Oncology

Biosimilars
Finance

Oncology biosimilars brought hospitals increased margins: study

A JAMA study outlines biosimilar acquisition costs that fell faster than reimbursement decreases as well as an accompanying jump in utilization.
Dave Muoio Mar 16, 2026 5:30pm
Fierce Podnosis podcast graphic featuring a stylized red-and-blue heart at center surrounded by curved orange and blue signa

How doctors are rethinking care as colorectal cancer shifts younger

Jan 28, 2026 9:21am
Businessmen shaking hands

Cencora to acquire majority stake in OneOncology for $5B

Dec 16, 2025 12:30pm
HLTH 25 womens health panel

HLTH25: Investors, founders urge more focus on women's health

Oct 23, 2025 10:40am
Podnosis

A cancer survivor's push to close the cold cap coverage gap

Oct 8, 2025 8:00am
Getty
Favicon Fierce Biotech

White House pledges $100M to AI pediatric cancer project

Oct 1, 2025 11:06am
More News

Cleveland Clinic to deploy AI for clinical trial recruitment

Aug 27, 2025 5:00pm

CancerIQ's latest tools support patients with higher cancer risk

Aug 27, 2025 11:00am

Aidoc lands $150M to build out clinical-grade foundation model

Jul 23, 2025 8:00am

Best Buy sells Current Health back to co-founder

Jun 30, 2025 2:00pm